Suppr超能文献

糖尿病肾病患者长期降压治疗停药后肾小球滤过率增加。

Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.

作者信息

Hansen H P, Rossing P, Tarnow L, Nielsen F S, Jensen B R, Parving H H

机构信息

Steno Diabetes Center, Gentofte, Denmark.

出版信息

Kidney Int. 1995 Jun;47(6):1726-31. doi: 10.1038/ki.1995.238.

Abstract

Initiation of antihypertensive treatment (AHT) in hypertensive insulin-dependent diabetic (IDDM) patients with diabetic nephropathy (DN) induces a faster initial (0 to 6 months) and a slower subsequent (6 months to end of observation) decline in GFR [delta GFR (ml/min/month) approximately 1.5 vs. 0.35]. Whether this initial phenomenon is reversible (hemodynamic) or irreversible (structural damage) after prolonged AHT is not known. To elucidate these mechanisms we investigated 42 hypertensive IDDM patients (16F/26M, age 40 +/- 7 years, mean +/- SD) with DN receiving AHT (angiotensin converting enzyme inhibition, N = 30) for 6 (2 to 15) years [median (range)]. GFR (ml/min/1.73 m2), arterial blood pressure (BP, mm Hg) and albuminuria (mg/24 hr) were measured the last day on AHT and one month after withdrawal of AHT. The measured variables were all significantly elevated after withdrawal of AHT: GFR [mean(SEM)] from 76(4) to 81(4) (P < 0.0001), BP [mean(SEM)] from 140/82 (2/1) to 151/89 (2/1) (P < 0.0005) and albuminuria [geometric mean (antilog SEM)] from 704 (1.2) to 1122 (1.2) (P < 0.0001). A correlation between relative rise in systolic blood pressure (delta Sys%) and relative change in GFR (delta GFR%) was found (r = 0.44, P < 0.005). Our results render some support of the hypothesis that the faster initial decline in GFR is due to a functional (hemodynamic) effect of AHT, which does not attenuate over time, while the subsequent slower decline reflects the beneficial effect on progression of diabetic nephropathy.

摘要

在患有糖尿病肾病(DN)的高血压胰岛素依赖型糖尿病(IDDM)患者中启动降压治疗(AHT),会导致肾小球滤过率(GFR)在初始阶段(0至6个月)下降更快,而在随后阶段(6个月至观察结束)下降更慢[GFR变化量(ml/分钟/月)约为1.5对0.35]。长期进行AHT后,这种初始现象是可逆的(血流动力学原因)还是不可逆的(结构损伤)尚不清楚。为了阐明这些机制,我们研究了42例接受AHT(血管紧张素转换酶抑制,N = 30)治疗6(2至15)年[中位数(范围)]的患有DN的高血压IDDM患者(16名女性/26名男性,年龄40±7岁,平均值±标准差)。在AHT的最后一天以及停用AHT一个月后,测量了GFR(ml/分钟/1.73平方米)、动脉血压(BP,毫米汞柱)和蛋白尿(毫克/24小时)。停用AHT后,所测量的变量均显著升高:GFR[平均值(标准误)]从76(4)升至81(4)(P < 0.0001),BP[平均值(标准误)]从140/82(2/1)升至151/89(2/1)(P < 0.0005),蛋白尿[几何平均值(反对数标准误)]从704(1.2)升至1122(1.2)(P < 0.0001)。发现收缩压相对升高(ΔSys%)与GFR相对变化(ΔGFR%)之间存在相关性(r = 0.44,P < 0.005)。我们的结果为以下假设提供了一些支持,即GFR初始阶段下降更快是由于AHT的功能性(血流动力学)效应,这种效应不会随时间减弱,而随后下降较慢则反映了对糖尿病肾病进展的有益作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验